Skip to main content
SpringerLink
Log in

Cardiac resynchronisation with defibrillator in HF: benefits at a cost

  • Unknown
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hadwiger M, et al. Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator. Applied Health Economics and Health Policy : 27 Mar 2020. Available from: URL: https://doi.org/10.1007/s40258-020-00571-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cardiac resynchronisation with defibrillator in HF: benefits at a cost. PharmacoEcon Outcomes News 850, 10 (2020). https://doi.org/10.1007/s40274-020-6698-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6698-4

Search

Navigation